Mountain Crest Acquisition II (Mountain Crest Acquisition II) Land And Improvements : $0.00 Mil (As of Oct. 2020)

View and export this data going back to 2021. Start your Free Trial

What is Mountain Crest Acquisition II Land And Improvements?

Mountain Crest Acquisition II's land and improvements for the quarter that ended in Oct. 2020 was $0.00 Mil.

Mountain Crest Acquisition II Land And Improvements Historical Data

The historical data trend for Mountain Crest Acquisition II's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Crest Acquisition II Land And Improvements Chart

Mountain Crest Acquisition II Annual Data

Trend

Dec20

Land And Improvements

Mountain Crest Acquisition II Semi-Annual Data
	Oct20
Land And Improvements	-

Mountain Crest Acquisition II Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Mountain Crest Acquisition II (Mountain Crest Acquisition II) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Mountain Crest Acquisition Corp II (NAS:MCADU) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

311 West 43rd Street, 12th Floor, New York, NY, USA, 10036

Website

Mountain Crest Acquisition Corp II is a blank check company.

Executives

Frank Karbe	director, officer: See Remarks	C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005
Elder Granger	director	5176 S. LEWISTON WAY, CENTENNIAL CO 80015
Richard H Carmona	director	1221 BROADWAY, OAKLAND CA 94612
Geoffrey M. Parker	director	15 RIORDAN PLACE, MENLO PARK CA 94025
Risa J Lavizzo-mourey	director	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661
Andrew J. Armanino	director	C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612
David P Perry	director, 10 percent owner, officer: See Remarks	1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303
Suying Liu	director	311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
David P. Perry 2015 Trust	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Mark A. Berman	officer: Chief Medical Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kevin J Appelbaum	director, 10 percent owner, officer: Chief Executive Officer	4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Mark Heinen	officer: See Remarks	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Justin Zamirowski	officer: Chief Commercial Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kristin Wynholds	officer: Chief Product Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104